MSB 2.51% 97.0¢ mesoblast limited

Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease, page-141

  1. 683 Posts.
    lightbulb Created with Sketch. 223
    Wow, it's amazing how even the educated in the field are living under a rock and don't even note MSC's as a solution in the possible treatment list.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.